May 20, 2026
30-Month Stay Explained: How Patent Litigation Delays Generic Drug Approval
Archive: 2026/09
Combination NTI Drugs and Generic Availability: Coverage and Gaps
Read More
Explore the critical gaps in generic availability for combination Narrow Therapeutic Index (NTI) drugs. Learn why bioequivalence standards create barriers, how substitution risks affect patient safety, and what monitoring strategies are essential for complex regimens.
